美国麻醉医师协会体格状态分级4级高共病负担患者行初次全关节置换术的并发症发生率及椎管内麻醉的益处
本研究利用美国外科医师学会国家手术质量改进计划注册数据,回顾性分析2014至2016年接受全关节置换术的ASA PS 4级患者,报告其30天死亡率、再入院率、并发症率和输血率,并比较椎管内麻醉与全身麻醉的结局差异。
要点
- ASA PS 4级患者行全关节置换术后30天死亡率为1.4%,再入院率为8.2%,并发症率为6.3%,输血率为11.8%。
- 与全身麻醉相比,椎管内麻醉与30天死亡率降低相关(OR 0.24,95%CI 0.12-0.49,P=0.0001)。
- 椎管内麻醉还与围手术期输血几率降低相关(OR 0.53,95%CI 0.45-0.65,P<0.0001)。
核心结论
- ASA PS 4级患者行全关节置换术的风险可能过高,不足以支持手术。
- 对于共病负担极高的患者,若行全关节置换术,椎管内麻醉是全身麻醉的合理替代方案。
研究设计与样本
- 回顾性分析,使用美国外科医师学会国家手术质量改进计划注册数据,纳入2014至2016年接受全关节置换术且年龄≥18岁的ASA PS 4级患者。
主要发现
- ASA PS 4级患者中,58例(1.4%)发生30天死亡,349例(8.2%)发生30天再入院,271例(6.3%)发生术后并发症,504例(11.8%)需要输血。
- 与全身麻醉相比,椎管内麻醉组30天死亡几率更低(OR 0.24,95%CI 0.12-0.49,P=0.0001)。
- 与全身麻醉相比,椎管内麻醉组围手术期输血几率更低(OR 0.53,95%CI 0.45-0.65,P<0.0001)。
临床怎么用
- 作者认为,ASA PS 4级患者行全关节置换术的风险可能过高,不足以支持手术。
- 作者认为,对于共病负担极高的患者,若行全关节置换术,椎管内麻醉是全身麻醉的合理替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American Society of Anesthesiologists physical status classification 4 (ASA PS 4) comprises patients with "severe systemic disease that is a constant threat to life." The purpose of this study is to conduct a retrospective analysis to report the rate of complications in the ASA PS 4 patients who undergo elective total joint arthroplasty (TJA). In addition, we report whether neuraxial anesthesia is associated with improved outcomes compared to general anesthesia in these patients. METHODS: The American College of Surgeons National Surgical Quality Improvement Program registry was used to extract patient records. The study population included patients aged ≥18 years who underwent TJA from 2014 to 2016 and who were classified as ASA PS 4. To measure differences in outcomes and patient characteristics, we used chi-squared tests. Odds ratios (ORs) and their 95% confidence intervals (CIs) were reported for all covariates. A P value of <.01 was selected. RESULTS: Among the patients who were ASA PS 4, 58 (1.4%) experienced 30-day mortality, 349 (8.2%) experienced 30-day readmission, 271 (6.3%) had a postoperative complication, and 504 (11.8%) required a transfusion. Those receiving neuraxial anesthesia compared to general anesthesia had lower odds of 30-day mortality (OR, 0.24; 95% CI, 0.12-0.49; P = .0001) and lower odds of perioperative transfusion (OR, 0.53; 95% CI 0.45-0.65; P < .0001). CONCLUSION: The elevated risks for ASA PS 4 patients undergoing TJA may be too high to justify surgery. Neuraxial anesthesia is a reasonable alternative to general anesthesia if pursuing TJA in patients with a very high comorbidity burden.
引用
- Chaturvedi R, Burton BN, Gabriel RA, et al. Complication Rates and the Benefits of Neuraxial Anesthesia in the Patient With High Comorbidity Burden Undergoing Primary Total Joint Arthroplasty. J Arthroplasty. 2020. PMID: 32636107. doi:10.1016/j.arth.2020.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。